Souza; Fabio E. S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Souza; Fabio E. S..The latest application filed is for "crystalline forms of tenofovir alafenamide".

Company Profile

25.25.32

Souza; Fabio E. S. - Brantford CA
Souza; Fabio E. S. - Mississauga CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Zuclomiphene salts and crystalline forms thereof Grant 11,440,871 - Raheem , et al. September 13, 2	2022-09-13
Crystalline Forms of Tenofovir Alafenamide App 20220235079 - Souza; Fabio E. S. ; et al.	2022-07-28
Crystalline form of Remdesivir Grant 11,377,456 - Souza , et al. July 5, 2	2022-07-05
Crystalline forms of Acalabrutinib Grant 11,345,706 - Souza , et al. May 31, 2	2022-05-31
Crystalline Form of Remdesivir App 20220144866 - Souza; Fabio E. S. ; et al.	2022-05-12
Processes for the Preparation of Zuclomiphene Intermediates App 20220119331 - Patel; Dineshkumar ; et al.	2022-04-21
Crystalline forms of niraparib tosylate Grant 11,236,066 - Stirk , et al. February 1, 2	2022-02-01
Salts of Zuclomiphene App 20210292272 - Souza; Fabio E. S. ; et al.	2021-09-23
Crystalline forms of Ponatinib hydrochloride Grant 11,072,620 - Souza , et al. July 27, 2	2021-07-27
Crystalline Forms of Zuclomiphene Citrate App 20210221767 - Souza; Fabio E. S. ; et al.	2021-07-22
Processes for the preparation of zuclomiphene and intermediates thereof Grant 11,046,638 - Karadeolian , et al. June 29, 2	2021-06-29
Zuclomiphene Salts and Crystalline Forms Thereof App 20210147338 - Raheem; Mohammed Abdul ; et al.	2021-05-20
Processes for the Preparation of Zuclomiphene and Intermediates Thereof App 20210147337 - Karadeolian; Avedis ; et al.	2021-05-20
Crystalline Forms of Acalabrutinib App 20210130360 - Souza; Fabio E. S. ; et al.	2021-05-06
Crystalline Forms of Niraparib Tosylate App 20210017151 - Stirk; Alexander J. ; et al.	2021-01-21
Crystalline form of lumacaftor Grant 10,858,346 - Souza , et al. December 8, 2	2020-12-08
Crystalline form of Eluxadoline Grant 10,822,309 - Souza , et al. November 3, 2	2020-11-03
Crystalline Form of Betrixaban Maleate App 20200317616 - Souza; Fabio E. S. ; et al.	2020-10-08
Crystalline form of Olaparib Grant 10,662,178 - Rey , et al.	2020-05-26
Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2 Grant 10,632,107 - Souza , et al.	2020-04-28
Crystalline form of Ribociclib succinate Grant 10,611,772 - Souza , et al.	2020-04-07
Crystalline Forms of Ponatinib Hydrochloride App 20200095255 - Souza; Fabio E. S. ; et al.	2020-03-26
Crystalline Form of Eluxadoline App 20200079740 - Souza; Fabio E. S. ; et al.	2020-03-12
Crystalline Form of Ribociclib Succinate App 20200002343 - Souza; Fabio E. S. ; et al.	2020-01-02
Processes for the Preparation of Dasotraline and Intermediates Thereof App 20190390235 - Souza; Fabio E. S. ; et al.	2019-12-26
Processes for the preparation of apalutamide and intermediates thereof Grant 10,513,504 - Bodhuri , et al. Dec	2019-12-24
Crystalline form of Eluxadoline Grant 10,487,059 - Souza , et al. Nov	2019-11-26
Crystalline Forms of Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 App 20190343815 - Souza; Fabio E.S. ; et al.	2019-11-14
Processes for the Preparation of Apalutamide and Intermediates Thereof App 20190276424 - Bodhuri; Prabhudas ; et al.	2019-09-12
Crystalline form of selexipag Grant 10,407,396 - Souza , et al. Sept	2019-09-10
Crystalline Form of Olaparib App 20190233400 - Rey; Allan W. ; et al.	2019-08-01
Crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-Y- L)-3-aminopropan-2-ol Grant 10,301,274 - Souza , et al.	2019-05-28
Crystalline Form of Selexipag App 20190144397 - Souza; Fabio E. S. ; et al.	2019-05-16
Crystalline Form of Lumacaftor App 20190112299 - Souza; Fabio E. S. ; et al.	2019-04-18
Crystalline Form of Eluxadoline App 20190092734 - Souza; Fabio E. S. ; et al.	2019-03-28
Crystalline forms of ibrutinib Grant 10,183,024 - Souza , et al. Ja	2019-01-22
Crystalline Forms of Ibrutinib App 20180153895 - Souza; Fabio E. S. ; et al.	2018-06-07
Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO.sub.2-(p-tolyl) groups Grant 9,850,254 - Souza , et al. December 26, 2	2017-12-26
Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein Grant 9,695,187 - Souza , et al. July 4, 2	2017-07-04
3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof Grant 9,650,397 - Souza , et al. May 16, 2	2017-05-16
Crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-Y- L)-3-aminopropan-2-ol App 20170066735 - Souza; Fabio E.s. ; et al.	2017-03-09
Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof Grant 9,416,140 - Souza , et al. August 16, 2	2016-08-16
Synthetic Process For Preparation Of Macrocyclic C1-keto Analogs Of Halichondrin B And Intermediates Useful Therein App 20160152631 - SOUZA; Fabio E.S. ; et al.	2016-06-02
Synthetic Process For Preparation Of Macrocyclic C1-keto Analogs Of Halichondrin B And Intermediates Useful Therein Including Intermediates Containing -so2-(p-tolyl) Groups App 20160137661 - SOUZA; Fabio E.S. ; et al.	2016-05-19
3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol Derivatives, Their Preparation And Intermediates Useful Thereof App 20160090391 - Souza; Fabio E.s. ; et al.	2016-03-31
Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein Grant 9,278,979 - Souza , et al. March 8, 2	2016-03-08
Process For Preparation Of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol Derivatives And Intermediates Useful Thereof App 20160031900 - SOUZA; Fabio E.S. ; et al.	2016-02-04
Process for preparation of (3R)-2,4-di-leaving group-3-methylbut-1-ene Grant 9,181,152 - Souza , et al. November 10, 2	2015-11-10
Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof Grant 9,174,956 - Souza , et al. November 3, 2	2015-11-03
2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsul- fonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation Grant 9,062,020 - Souza , et al. June 23, 2	2015-06-23
Process For Preparation Of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol Derivatives And Intermediates Useful Thereof App 20150073157 - Souza; Fabio E.S. ; et al.	2015-03-12
Synthetic Process For Preparation Of Macrocyclic C1-keto Analogs Of Halichondrin B And Intermediates Useful Therein App 20150065733 - Souza; Fabio E.S. ; et al.	2015-03-05
2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsul- Fonylmethyl)tetrahydrofuran-2-yl)acetaldehyde Derivatives And Process For Their Preparation App 20150011776 - Souza; Fabio E.S. ; et al.	2015-01-08
Process For Preparation Of (3r)-2,4-di-leaving Group-3-methylbut-1-ene App 20140323744 - Souza; Fabio E.S. ; et al.	2014-10-30
Intermediate Compounds In The Synthesis Of Dronabinol App 20080312465 - SOUZA; Fabio E.S. ; et al.	2008-12-18
Synthetic route to dronabinol Grant 7,323,576 - Souza , et al. January 29, 2	2008-01-29
Synthetic route to dronabinol App 20060074252 - Souza; Fabio E.S. ; et al.	2006-04-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.